葡萄糖耐量

  • 网络glucose tolerence;Glucose tolerance;OGTT;IGT
葡萄糖耐量葡萄糖耐量
  1. 心力衰竭患者血浆胰岛素水平及葡萄糖耐量变化与T3和肾素关系

    Serum Insulin and OGTT in Heart Failure Patients and its Related with T 3 and Serum Renin

  2. 两组均测试服用前后葡萄糖耐量、胰岛素、C肽及糖化血红蛋白。

    The glucose tolerance , insulin , C-peptide and HbA1c were measured before and after treatment .

  3. 检查血糖、血脂、葡萄糖耐量及胰岛素C肽释放试验。

    The survey includes tests of blood glucose , lipids , OGTT , insulin , and C-peptide , etc.

  4. 方法用ONETOUCHBASIC微量血糖测试仪检测用药前后的血糖和葡萄糖耐量试验中的血糖,放免法测定C肽。

    Methods Blood glucose was detected by ONE TOUCH BASIC blood Glucose Monitoring System . The C - peptide was measured by radioimmunology method .

  5. 方法36例肝硬化患者与30例正常人进行口服葡萄糖耐量及胰岛素释放试验同时测定C肽,测定胰岛素敏感性。

    Method 36 cirrhosis patients and 30 healthy controls were enrolled in the OGTT and insulin releasing test . Meanwhile the CP levels and insulin sensitivity index were measured .

  6. 铬是人体必需的微量营养元素之一,是人体内葡萄糖耐量因子(glucosetolerancefactor,GTF)的重要组成成分。

    Chromium is one of the essential trace elements and the most important component of glucose tolerance factor ( GTF ) .

  7. 口服葡萄糖耐量试验诊断DM、IGT、IFG的临床意义

    Clinical Significance of OGTT in Diagnosis of DM , IGT and IFG

  8. 100g口服葡萄糖耐量试验与妊娠糖尿病

    100 g oral glucose tolerance test in patients with gestational diabetes mellitus

  9. 100g口服葡萄糖耐量试验中低血糖的发生率和围生期意义

    Hypoglycemia during the 100-g oral glucose tolerance test : Incidence and perinatal significance

  10. 方法:对21名正常人和71例肝硬化患者进行葡萄糖耐量试验、胰岛素和C肽释放试验,肝硬化组按葡萄糖耐量试验结果分为4小组。

    Methods : Tests for oral glucose tolerance ( OGTT ), insulin level and C-peptide release were performed in 71 liver cirrhosis patients and 21 controls . Patients were subdivided into four groups according to OGTT .

  11. 目的:了解葡萄糖耐量低减(IGT)患者掌握糖尿病知识的情况及健康教育后IGT患者血糖及血脂的变化。

    Objective : To understand patients'diabetic mellitus knowledge and BS , serum lipid change after health education .

  12. 目的探索葡萄糖耐量减低(IGT)与新诊断糖尿病人的临床特征。

    Objective To evaluate the clinical characteristics of impaired glucose tolerance ( IGT ) and new-diagnosed diabetes .

  13. 葡萄糖耐量减低(IGT)患者性激素水平随年龄变化的研究

    The study of the change The Impaired Glucose Tolerance patient 's sex hormone level in different age

  14. 放免法检测葡萄糖耐量试验时血清免疫活性胰岛素(IRI)、C肽(CP)。

    During oral glucose tolerance test ( OGTT ) serum immunoreactive insulin ( IRI ) and C peptide ( CP ) were measured by radioimmunoassay .

  15. 口服葡萄糖耐量实验结果显示,C57BL/6小鼠各组之间的葡萄糖负荷前后的血糖水平变化趋势均无明显差异(P0.05)。

    OGTT results showed that the variation of serum glucose levels had no significant differences ( P0.05 ) between each group in C57BL / 6 mice before and after the glucose load .

  16. 目的研究空腹和75g口服葡萄糖耐量2h血糖与超声检测的动脉僵硬度指标的关系。

    Objective To investigate the relationship of glycaemia level and the artery stiffness by means of ultrasonography .

  17. 腹腔葡萄糖耐量试验(IPGTT)检测大鼠胰岛功能,ELISA法测定血中胰岛素浓度。

    Intraperitoneal glucose tolerance tests ( IPGTT ) and ELISA were done to detect the function of pancreatic islet .

  18. 给小蘖碱后,可以改善KK小鼠的葡萄糖耐量。

    After administration of berberine for 15 days , the glucose tolerance of KK mice showed improvement .

  19. 目的探讨糖调节异常(IGR)的自然转归及比较空腹血糖受损(IFG)和葡萄糖耐量异常(IGT)之间相关因素的异同。

    Objective To investigate the natural results of IGR and to compare the correlation factor between IFG and IGT .

  20. 口服葡萄糖耐量试验和胰岛素释放试验,测定血浆葡萄糖浓度、血清胰岛素浓度、FFA水平。

    Oral glucose tolerance test and insulin release test were carried out to measure plasma glucose concentrations , serum insulin concentrations and serum FFA levels .

  21. 方法南京地区机关背景1163例无糖尿病史成人,均行75g口服葡萄糖耐量试验。

    Methods Seventy-five gram oral glucose tolerance tests were performed in 1163 individuals .

  22. 于服药8周后测空腹血糖(FPG)、葡萄糖耐量实验(OGTT)、糖化血红蛋白(HbA1c)以及中医症候的前后变化。

    After 8 weeks , the condition of FPG , OGTT , HbAlc on an empty stomach and changes of syndrome were detected .

  23. 其空腹基础胰岛素水平正常,但葡萄糖耐量试验胰岛素水平较对照组明显降低,2h胰岛素分泌有延迟现象;

    The fast serum insulin level was normal , but in oral glucose test , the secretion of insulin was reduced markedly and a phenomenon of delayed secretion was observed .

  24. 方法对2882例无2型糖尿病(T2DM)史的受试者进行口服葡萄糖耐量试验。

    Methods A total of 2882 subjects without history of type 2 diabetes mellitus ( T2DM ) received oral glucose tolerance test ( OGTT ) .

  25. 研究背景与研究目的葡萄糖耐量受损(IGT)已经被公认为是CVD的一个重要标志,其携带的心血管风险接近于糖尿病。

    Background and objectives : Impaired glucose tolerance ( IGT ) is widely postulated as an important risk marker for CVD and is near to T2DM in regard of carrying CVD risk .

  26. 上述动物于第8周末,用血糖仪测定空腹血糖和口服葡萄糖耐量试验后2h血糖。

    At the end of the 8th week , the fasting blood glucose and the glucose 2 hours after the orally taken glucose tolerance test were measured by the Blood Glucose Meter ;

  27. 目的探索从富铬酵母中提取葡萄糖耐量因子(GTF)的方法,分析提取液中氨基酸含量。

    Objective To study method of GTF abstracted from chromium-rich brewer 's yeast , determine content of amino acid in abstract .

  28. 虽葡萄糖耐量曲线上移,但均未出现糖耐量损伤(IGT)或糖尿病(DM)。

    Although a upward displacement of glucose curve after r - hGH treatment was observed , impaired glucose tolerance ( IGT ) and diabetes mellitus ( DM ) were not found in all patients .

  29. 目的建立一个利用口服葡萄糖耐量试验(OGTT)评估机体胰岛素敏感性和分泌功能的新数学模型。

    Objective To develop a mathematical model from modifying Bergman ′ s minimal model to evaluate the insulin sensitivity and secretion function by 75 g OGTT data .

  30. 对其中15例在治疗前及治疗后3个月进行口服葡萄糖耐量试验(OGTT)和胰岛素(INS)释放试验(IRT)。

    Oral glucose tolerance test ( OGTT ) and insulin releasing test ( IRT ) were also performed 3 months before and after the therapy in 15 children with GHD .